Biggest News Aggregation in the World
๐Ÿ“ฐ Cipher Pharmaceuticals News

Page 2 - Cipher Pharmaceuticals News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Cipher Pharmaceuticals. Real-time updates on events, politics, business and more.

Cipher Pharmaceuticals (TSE:CPH) PT Raised to C$8.00

Cipher Pharmaceuticals (TSE:CPH – Free Report) (NASDAQ:CPHR) had its target price boosted by Citigroup from C$4.75 to C$8.00 in a report published on Wednesday, BayStreet.CA reports. They currently have a buy rating on the stock. Cipher Pharmaceuticals Stock Performance Shares of TSE CPH opened at C$7.70 on Wednesday. The business’s 50-day moving average price is […]
Cipher Pharmaceuticals Stock Performance News Ratings For Cipher Pharmaceuticals Daily Cipher Pharmaceuticals Cipher Pharmaceuticals Company Profile Cipher Pharmaceuticals Inc Free Report
Source: wkrb13.com

Cipher Pharmaceuticals (TSE:CPH) Given New C$8.00 Price Target at Citigroup

Cipher Pharmaceuticals (TSE:CPH – Get Free Report) (NASDAQ:CPHR) had its target price lifted by research analysts at Citigroup from C$4.75 to C$8.00 in a research note issued to investors on Wednesday, BayStreet.CA reports. The firm presently has a “buy” rating on the stock. Citigroup’s price objective points to a potential upside of 12.68% from the […]
Cipher Pharmaceuticals Stock Cipher Pharmaceuticals Cipher Pharmaceuticals Inc News Ratings For Cipher Pharmaceuticals Daily Get Free Report Pharmaceuticals Inc

Cipher Pharmaceuticals (OTCMKTS:CPHRF) Shares Pass Above Fifty Day Moving Average of $3.95

Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF – Get Free Report) (TSE:CPH) passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $3.95 and traded as high as $4.35. Cipher Pharmaceuticals shares last traded at $4.35, with a volume of 600 shares. Cipher Pharmaceuticals Stock Down 0.9 % The […]
Cipher Pharmaceuticals Stock Down News Ratings For Cipher Pharmaceuticals Daily Cipher Pharmaceuticals Inc Cipher Pharmaceuticals Company Profile Cipher Pharmaceuticals Get Free Report

Cipher Pharmaceuticals (TSE:CPH) Hits New 12-Month High at $6.35

Cipher Pharmaceuticals Inc. (TSE:CPH – Get Free Report) (NASDAQ:CPHR)’s share price reached a new 52-week high during mid-day trading on Monday . The company traded as high as C$6.35 and last traded at C$6.23, with a volume of 39301 shares trading hands. The stock had previously closed at C$6.22. Cipher Pharmaceuticals Trading Up 0.6 % […]
Cipher Pharmaceuticals Trading Cipher Pharmaceuticals News Ratings For Cipher Pharmaceuticals Daily Cipher Pharmaceuticals Inc Get Free Report Pharmaceuticals Inc
Source: wkrb13.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Cipher Pharmaceuticals (TSE:CPH) Reaches New 1-Year High at $6.35

Cipher Pharmaceuticals Inc. (TSE:CPH – Get Free Report) (NASDAQ:CPHR)’s stock price reached a new 52-week high during trading on Monday . The company traded as high as C$6.35 and last traded at C$6.23, with a volume of 39301 shares changing hands. The stock had previously closed at C$6.22. Cipher Pharmaceuticals Trading Up 0.6 % The […]
Cipher Pharmaceuticals Trading Cipher Pharmaceuticals Company Profile Cipher Pharmaceuticals Inc News Ratings For Cipher Pharmaceuticals Daily Cipher Pharmaceuticals Get Free Report

Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF) Sees Significant Increase in Short Interest

Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF – Get Free Report) (TSE:CPH) was the target of a significant increase in short interest during the month of October. As of October 31st, there was short interest totalling 5,500 shares, an increase of 223.5% from the October 15th total of 1,700 shares. Based on an average daily volume of 7,300 […]
Cipher Pharmaceuticals Price Performance Cipher Pharmaceuticals Inc Cipher Pharmaceuticals Company Profile Cipher Pharmaceuticals News Ratings For Cipher Pharmaceuticals Daily Get Free Report

Actinic Keratosis Treatment Industry's Impressive CAGR of 7.0% Enroot to US$ 8.0 Billion by 2028 | FMI

The global Actinic Keratosis Treatment Industry is on an impressive growth trajectory, according to the latest report by Future Market Insights (FMI). In 2022, the market was valued at approximately US$ 5.4 billion, and it is projected to reach an astounding US$ 8.0 billion by 2028, with an expected compound annual...
United States New York Leo Pharma Astellas Pharma Valeo Pharma Inc Galderma Sa Nestle Skin Health Company

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science